PharmaResearch Co., Ltd.
214450.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
263
Cost of Revenue
74
Gross Profit
188
Gross Margin
71.8%
Operating Income
95
Operating Margin
36.0%
Net Income
69
Net Margin
26.3%
EPS (Basic)
$7.00
EPS (Diluted)
$7.00
EBITDA
101
EBITDA Margin
38.3%
2023
12/31/2023
Revenue
196
Cost of Revenue
53
Gross Profit
143
Gross Margin
72.9%
Operating Income
76
Operating Margin
38.6%
Net Income
57
Net Margin
29.3%
EPS (Basic)
$6.00
EPS (Diluted)
$6.00
EBITDA
86
EBITDA Margin
44.1%
2022
12/31/2022
Revenue
146
Cost of Revenue
45
Gross Profit
101
Gross Margin
68.9%
Operating Income
49
Operating Margin
33.8%
Net Income
30
Net Margin
20.8%
EPS (Basic)
$3.00
EPS (Diluted)
$3.00
EBITDA
57
EBITDA Margin
39.3%
2021
12/31/2021
Revenue
116
Cost of Revenue
39
Gross Profit
76
Gross Margin
66.2%
Operating Income
39
Operating Margin
34.1%
Net Income
35
Net Margin
30.3%
EPS (Basic)
$4.00
EPS (Diluted)
$4.00
EBITDA
50
EBITDA Margin
43.0%
2020
12/31/2020
Revenue
82
Cost of Revenue
31
Gross Profit
51
Gross Margin
62.1%
Operating Income
25
Operating Margin
30.7%
Net Income
25
Net Margin
30.1%
EPS (Basic)
$3.00
EPS (Diluted)
$3.00
EBITDA
31
EBITDA Margin
38.4%